Search

You searched for "OHT"

1895 results found

Introducing: the Glaucoma Field Defect Classifier

12 August 2025 | glaucoma, diagnositics, technology, CVI
For patients with advanced glaucoma, there are no treatments to reverse severe sight impairment (blindness). Support in the community is essential but requires a certificate of visual impairment (CVI) signed by a consultant ophthalmologist. The criteria for certification are ambiguous...
Journal of Neuro-Ophthalmology cover image.

Pilot trial of Fluoxetine for post-stroke homonymous hemianopia

3 April 2024 | | EYE - Neuro-ophthalmology
The authors present a pilot randomised placebo controlled double blind trial assessing 20mg fluoxetine once daily for 90 days versus placebo in stroke survivors with isolated homonymous hemianopia. Exclusion criteria were extensive in terms of pre-existing ophthalmic or neurologic disease,...

British Council for Prevention of Blindness publishes annual review

12 January 2021
The British Council for Prevention of Blindness has published its new annual review.

UKNOS (UK Neuro-ophthalmology Society) Annual Meeting 2024

8 February 2024
UKNOS 2023 sold out so book here now at early bird rates to avoid disappointment & save on cost Newcastle will host our next annual meeting on Feb 8th 2024, focused on Managing Uncertainty(ies) in Neuro-Ophthalmology - join us and...

Moorfields Education: Ocular Emergencies Level 1

5 February 2024
This three-month course is open to optometrists, orthoptists, nurses and other allied ophthalmic health professionals. You’ll learn about the knowledge and skills required for the examination, investigation, diagnosis, treatment, and management of patients who present in an ophthalmic emergency setting....

UKEGS Conference 2025

5 November 2025 -6 November 2025
UKEGS (UK and Éire Glaucoma Society) Conference 2025

See sweet to C-suite: Carrie MacEwen

2 April 2025 | | EYE - General
The business world tells us, “Know your why.” But increasingly, we live in a society where people think, “Why bother?” In this interview, David wants to know what makes Carrie MacEwen tick, and why she bothered to get involved locally,...

Designing ophthalmology services Part 2: How do we address the queues for a clinic?

1 April 2020 | | EYE - General
The first of this three-part series showed how systems engineering can be used to correctly diagnose and address the causes of delays in a clinic. This second article describes how to design a more productive system that meets the new...

ST3 Trainee experience of cataract surgery training in high flow settings in the independent sector

5 June 2023 | | EYE - Cataract, EYE - Refractive
As an ST3 trainee, I was provided with the opportunity to complete a surgical training rotation at Newmedica Middlesborough, which involved cataract training on NHS patients undergoing surgery in the independent sector (IS). This reflective account highlights the experience from...

An eye on novel anti-cancer agents: an evidence-based approach to external eye assessment

5 April 2022 | | EYE - Cornea, EYE - General
Novel anti-cancer therapies have led to significant advancement in cancer treatment, however, they can be associated with external eye complications. It is important to be mindful of such adverse effects during assessment of patients enrolled in clinical trials. Annually, approximately...

Preview: UKEGS 2024

24 September 2024 | conferences, reports, UKEGS, glaucoma, Nishani Amerasinghe, Andrew Tatham, Gus Gazzard, Glaucoma UK, events, meetings
Pretty soon it’s going to be the 9th of October, and a quick Wikipedia search will tell you of how this day in history has seen the founding of the Kingdom of Valencia, the initial whispers of the Prague Astronomical...

Treatment of diabetic macular oedema

1 June 2014 | | EYE - Vitreo-Retinal
Diabetic macular oedema (DMO) is a common complication associated with diabetic retinopathy, and the most common cause of visual impairment in diabetes [1]. With predicted rising levels of diabetes (in England by 2025 the estimated population with diabetes will be...